This study is the first to demonstrate that peripheral blood CD8+CD28− T cells can serve as an independent prognostic factor for recurrence and distant metastasis in patients with NPC after radiotherapy, especially in patients with low EBV DNA levels. The gene discussed is CD8A; the disease is nasopharyngeal carcinoma.